BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33968692)

  • 1. Mutational landscape of thymic epithelial tumors in a Chinese population: insights into potential clinical implications.
    Wang H; Xu X; Luo L; Wang C; Jiang Z; Lin Y
    Gland Surg; 2021 Apr; 10(4):1410-1417. PubMed ID: 33968692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic characterization of thymic epithelial tumors in a real-world dataset.
    Kurokawa K; Shukuya T; Greenstein RA; Kaplan BG; Wakelee H; Ross JS; Miura K; Furuta K; Kato S; Suh J; Sivakumar S; Sokol ES; Carbone DP; Takahashi K
    ESMO Open; 2023 Oct; 8(5):101627. PubMed ID: 37703595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients.
    Liang N; Liu L; Huang C; Liu H; Guo C; Li J; Wang W; Li N; Lin R; Wang T; Ding L; Mao L; Li S
    Front Oncol; 2021; 11():647512. PubMed ID: 34568003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors.
    Xu S; Li X; Zhang H; Zu L; Yang L; Shi T; Zhu S; Lei X; Song Z; Chen J
    Front Oncol; 2021; 11():667148. PubMed ID: 34307137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic alterations in thymoma-molecular pathogenesis?
    Oberndorfer F; Müllauer L
    J Thorac Dis; 2020 Dec; 12(12):7536-7544. PubMed ID: 33447444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic characterization of thymic epithelial tumors reveals critical genes underlying tumorigenesis and poor prognosis.
    Tan S; Chen J; Wang Z; Zhao X; Sun Y; Zhu Y; Gong Z; Zhang D
    Clin Genet; 2023 May; 103(5):529-539. PubMed ID: 36541162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive Biomarkers.
    Girard N; Basse C; Schrock A; Ramkissoon S; Killian K; Ross JS
    Oncologist; 2022 Nov; 27(11):919-929. PubMed ID: 35749302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review.
    Elm L; Levidou G
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.
    Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B
    Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
    Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
    Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.
    Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L
    Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of epigenetic regulatory genes are common in thymic carcinomas.
    Wang Y; Thomas A; Lau C; Rajan A; Zhu Y; Killian JK; Petrini I; Pham T; Morrow B; Zhong X; Meltzer PS; Giaccone G
    Sci Rep; 2014 Dec; 4():7336. PubMed ID: 25482724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and Immunotherapies.
    Cao J; Chen L; Li H; Chen H; Yao J; Mu S; Liu W; Zhang P; Cheng Y; Liu B; Hu Z; Chen D; Kang H; Hu J; Wang A; Wang W; Yao M; Chrin G; Wang X; Zhao W; Li L; Xu L; Guo W; Jia J; Chen J; Wang K; Li G; Shi W
    Oncologist; 2019 Dec; 24(12):e1294-e1302. PubMed ID: 31409745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers.
    Tagliamento M; Morfouace M; Loizides C; Oliveira J; Greillier L; Raimbourg J; Toffart AC; Chatellier T; Cloarec N; Sullivan I; Brasiuniene B; Duruisseaux M; Oselin K; Robert MS; Fernandes C; Poncin A; Blay JY; Besse B; Girard N
    NPJ Precis Oncol; 2024 Feb; 8(1):37. PubMed ID: 38366021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular landscape of thymic epithelial tumors.
    Prays J; Ortiz-Villalón C
    Semin Diagn Pathol; 2022 Mar; 39(2):131-136. PubMed ID: 34272124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas.
    Zhang Q; Yang Y; You X; Ju Y; Zhang Q; Sun T; Liu W
    Front Oncol; 2023; 13():1173275. PubMed ID: 37546405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the tumor microenvironment and mutation burden identifies prognostic features in thymic epithelial tumors.
    Hou X; Lin S; Liu Y; Wang K; Yu Z; Jia J; Yu J; Zheng W; Bai J; Chang L; Chen J; Li M; Chen L
    Am J Cancer Res; 2022; 12(5):2387-2396. PubMed ID: 35693087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors.
    Song JS; Kim D; Kwon JH; Kim HR; Choi CM; Jang SJ
    Front Oncol; 2019; 9():1055. PubMed ID: 31681591
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in
    Szpechcinski A; Szolkowska M; Winiarski S; Lechowicz U; Wisniewski P; Knetki-Wroblewska M
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets.
    Shimada M; Taniguchi H; Yamaguchi H; Gyotoku H; Sasaki D; Kaku N; Senju C; Senju H; Imamura E; Takemoto S; Yamamoto K; Sakamoto N; Obase Y; Tsuchiya T; Fukuda M; Soda H; Ashizawa K; Fukuoka J; Nagayasu T; Yanagihara K; Mukae H
    Transl Lung Cancer Res; 2023 Apr; 12(4):707-718. PubMed ID: 37197618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.